Neogen Corp
NEOG10.800USD
+0.210+1.98%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
2.35BMarket Cap
LossP/E TTM
More Details of Neogen Corp Company
Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.
Neogen Corp Info
Ticker SymbolNEOG
Company nameNeogen Corp
IPO dateAug 23, 1989
CEONassif (Mikhael)
Number of employees2974
Security typeOrdinary Share
Fiscal year-endAug 23
Address620 Lesher Pl
CityLANSING
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code48912
Phone15173729200
Websitehttps://www.neogen.com/
Ticker SymbolNEOG
IPO dateAug 23, 1989
CEONassif (Mikhael)
Company Executives of Neogen Corp
Name
Name/Position
Position
Shareholding
Change
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
116.12K
+25642.00%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Operating Officer
Chief Operating Officer
90.39K
+9364.00%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
57.24K
+13070.00%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
45.53K
+23617.00%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
36.86K
+23617.00%
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
36.40K
+23617.00%
Ms. Andrea F. Wainer
Ms. Andrea F. Wainer
Independent Director
Independent Director
25.86K
+19769.00%
Mr. Thierry Bernard
Mr. Thierry Bernard
Independent Director
Independent Director
25.39K
+19769.00%
Mr. Avi Pelossof
Mr. Avi Pelossof
Director
Director
19.39K
+19386.00%
Mr. Raphael A. (Ralph) Rodriguez
Mr. Raphael A. (Ralph) Rodriguez
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
116.12K
+25642.00%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Operating Officer
Chief Operating Officer
90.39K
+9364.00%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
57.24K
+13070.00%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
45.53K
+23617.00%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
36.86K
+23617.00%
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
36.40K
+23617.00%
Revenue Breakdown
Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Culture Media & Other
79.08M
37.81%
Bacterial & General Sanitation
41.65M
19.91%
Rodenticides, Insecticides & Disinfectants
25.03M
11.96%
Genomics Services
22.12M
10.57%
Natural Toxins, Allergens & Drug Residues
19.96M
9.54%
Other
21.34M
10.20%
By RegionUSD
Name
Revenue
Proportion
International
107.11M
51.20%
Domestic
102.07M
48.80%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Culture Media & Other
79.08M
37.81%
Bacterial & General Sanitation
41.65M
19.91%
Rodenticides, Insecticides & Disinfectants
25.03M
11.96%
Genomics Services
22.12M
10.57%
Natural Toxins, Allergens & Drug Residues
19.96M
9.54%
Other
21.34M
10.20%
Shareholding Stats
Updated: Sat, Feb 7
Updated: Sat, Feb 7
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.45%
The Vanguard Group, Inc.
10.92%
Clarkston Capital Partners, LLC
5.38%
Gates Capital Management, Inc.
5.01%
Norges Bank Investment Management (NBIM)
4.17%
Other
61.07%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.45%
The Vanguard Group, Inc.
10.92%
Clarkston Capital Partners, LLC
5.38%
Gates Capital Management, Inc.
5.01%
Norges Bank Investment Management (NBIM)
4.17%
Other
61.07%
Shareholder Types
Shareholders
Proportion
Investment Advisor
47.67%
Investment Advisor/Hedge Fund
32.30%
Hedge Fund
12.45%
Research Firm
8.48%
Bank and Trust
4.89%
Sovereign Wealth Fund
4.24%
Pension Fund
1.89%
Individual Investor
0.94%
Insurance Company
0.03%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
734
243.39M
111.89%
-91.48M
2025Q3
733
254.38M
117.06%
-53.44M
2025Q2
720
240.23M
110.60%
-42.75M
2025Q1
753
280.62M
129.30%
-9.42M
2024Q4
764
265.86M
122.55%
-15.84M
2024Q3
778
258.29M
119.19%
-21.39M
2024Q2
791
255.45M
117.89%
-8.15M
2024Q1
783
241.86M
111.66%
-5.94M
2023Q4
783
234.38M
108.27%
-1.28M
2023Q3
770
225.33M
104.20%
-18.20M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
29.26M
13.46%
+1.70M
+6.18%
Sep 30, 2025
The Vanguard Group, Inc.
23.92M
11.01%
+385.88K
+1.64%
Sep 30, 2025
Clarkston Capital Partners, LLC
11.69M
5.38%
-2.31M
-16.51%
Sep 30, 2025
Gates Capital Management, Inc.
10.90M
5.02%
-1.89M
-14.80%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
9.08M
4.18%
-5.73M
-38.70%
Jun 30, 2025
State Street Investment Management (US)
8.75M
4.03%
+158.17K
+1.84%
Sep 30, 2025
ING Bank N.V.
8.67M
3.99%
-5.39M
-38.31%
Nov 28, 2025
Dimensional Fund Advisors, L.P.
8.03M
3.69%
-1.11M
-12.12%
Sep 30, 2025
Mackenzie Investments
7.82M
3.6%
+6.35K
+0.08%
Sep 30, 2025
Baron Capital Management, Inc.
6.85M
3.15%
+684.00
+0.01%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
State Street SPDR S&P Health Care Equipment ETF
1.97%
Invesco S&P SmallCap Health Care ETF
0.82%
Invesco NASDAQ Future Gen 200 ETF
0.58%
VanEck Agribusiness ETF
0.32%
Federated Hermes MDT Small Cap Core ETF
0.27%
Inspire Small/Mid Cap ESG ETF
0.22%
Amplify Etho Climate Leadership U.S. ETF
0.21%
Invesco S&P SmallCap 600 Pure Value ETF
0.2%
State Street SPDR S&P 600 Small Cap Value ETF
0.18%
iShares S&P Small-Cap 600 Value ETF
0.18%
View more
State Street SPDR S&P Health Care Equipment ETF
Proportion1.97%
Invesco S&P SmallCap Health Care ETF
Proportion0.82%
Invesco NASDAQ Future Gen 200 ETF
Proportion0.58%
VanEck Agribusiness ETF
Proportion0.32%
Federated Hermes MDT Small Cap Core ETF
Proportion0.27%
Inspire Small/Mid Cap ESG ETF
Proportion0.22%
Amplify Etho Climate Leadership U.S. ETF
Proportion0.21%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.2%
State Street SPDR S&P 600 Small Cap Value ETF
Proportion0.18%
iShares S&P Small-Cap 600 Value ETF
Proportion0.18%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
May 12, 2021
Split
1→2
Date
Ex-dividend Date
Type
Ratio
May 12, 2021
Split
1→2
